|Day Low/High||24.40 / 24.99|
|52 Wk Low/High||14.45 / 26.49|
The charts of the cannabis producer indicate that its shares have found a support level.
These 12 companies likely saw their shares hurt by tax-loss selling at the end of 2018, but most are outperforming the market so far this year.
The company's first move into the cannabis space is in a joint venture with medical marijuana research company Emerald Farms.
We have to own that it was a bad day for the bulls and that it's perfectly realistic to expect a few more until the facts get more positive.
So far nine are in positive territory, and are up an average of just over 11%.
With eight of the 12 names in positive territory so far, up an average of 3.2%, they are off to a decent start.
All of these companies have been hammered to a varying degree during the year but trade at reasonable forward valuations.
AMD continues to surge, after significant year-over-year improvements almost everywhere.
Shares of Hain Celestial moved lower Tuesday amid downbeat quarterly results.
TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on Tuesday's trending stocks from the floor of the New York Stock Exchange.
The key thing about investing mistakes is taking the time to learn from them.
The key thing about investing mistakes it taking the trouble to learn from them.
Presidential tweets, North Korea missiles, higher interest rates? Big deal.
Netflix' power means that the stock is likely to go higher, not lower.
The S&P 500 ended the day at new records with just small gains. Consumer stocks did most of the heavy-lifting.
Jim Cramer weighs in on the trending news of the day from the floor of the New York Stock Exchange.
Jim Cramer does not think Hain Celestial is for sale despite striking a deal with an activist investor.
Charts suggest gains may be brewing for Hain Celestial.
What's next for Hain Celestial shares?
This was never a deal about raising gross margins.
Stocks are mostly higher to end the week as benchmark indexes look to close out the second quarter with healthy gains.